Pharmaceutical formulations containing a mixture of higher primary aliphatic alcohols in the treatment of hypercholesterolaemia and hyperlypoproteinaemia type II and stimulation of sexual behavior in animals and humans.

摘要

The present invention relates to the pharmaceutical industry and, in particular, to formulations presenting hypercholesterolaernic activity and reduction of LDL levels (Low Density Lipoproteins), as well as important properties for the enhancement of sexual capacity in animals. The main objective of this invention is to elaborate different pharmaceutical formulations for its oral and parenteral administration, aimed at lowering blood cholesterol, triglycerides and low density lipoproteins. As an active compound, these formulations contain a mixture of saturated primary alcohols having a straight chain ranging from 24 to 34 carbon atoms in specific relation to each other.